Advertisement
Screener

Crossmark Global Holdings, Inc. Historic Quarter Change: Foreign Other Stocks, Added

Crossmark Global Holdings, Inc. historic quarter change: Foreign Other Stocks, Added

In shares no fund filing gives a ticker for, so this site has no page for them (depositary receipts and foreign shares traded over the counter), over 10 quarters from 2023-12-31 to 2026-06-30, Crossmark Global Holdings, Inc. opened 3 positions, added to 8, reduced 11 and sold out of 10.

  • Q4 2024: Stock TOTAL FINA ELF S A ADR SPONS; Country of operation —; Class COM; Shares before 167,364.
  • Q4 2024: Stock JAMES HARDIE INDS N V SPONSORE; Country of operation —; Class COM; Shares before 51,996.
  • Q4 2024: Stock ASCENDIS PHARMA A/S SPONSORED; Country of operation —; Class COM; Shares before 8,120.
  • Q4 2024: Stock CRITEO S A SPONS ADS; Country of operation —; Class COM; Shares before 10,957.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1539204), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-07-16); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-11); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-03); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-12); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-08); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-04-30); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-01-16); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-04); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-07-29); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-13). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2016-09-30.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q4 2024TOTAL FINA ELF S A ADR SPONS
CUSIP 89151E109
COM167,364170,305+2,941$10,815$9,281-$1,5342025-01-16
Q4 2024JAMES HARDIE INDS N V SPONSORE
CUSIP 47030M106
COM51,99652,416+420$2,088$1,615-$4732025-01-16
Q4 2024ASCENDIS PHARMA A/S SPONSORED
CUSIP 04351P101
COM8,12010,435+2,315$1,212$1,436+$2242025-01-16
Q4 2024CRITEO S A SPONS ADS
CUSIP 226718104
COM10,95710,989+32$441$435-$62025-01-16
Q3 2024TOTAL FINA ELF S A ADR SPONS
CUSIP 89151E109
COM112,886167,364+54,478$7,527$10,815+$3,2882024-11-04
Q3 2024JAMES HARDIE INDS N V SPONSORE
CUSIP 47030M106
COM28,27351,996+23,723$892$2,088+$1,1962024-11-04
Q3 2024ASTRAZENECA PLC ADR SPONSORED
CUSIP 046353108
COM40,48253,438+12,956$3,157$4,164+$1,0072024-11-04
Q2 2024ASTRAZENECA PLC ADR SPONSORED
CUSIP 046353108
COM39,17940,482+1,303$2,654$3,157+$5032024-07-29

Similar Firms

Firm NameCountry13F ValueHoldings
Jericho Capital Asset Management L.P.United States$6.765B23
CANTOR FITZGERALD, L. P.United States$6.776B270
CBRE INVESTMENT MANAGEMENT LISTED REAL ASSETS LLCUnited States$6.746B96
TOCQUEVILLE ASSET MANAGEMENT L.P.United States$6.744B547
Apella Capital, LLCUnited States$6.738B687
Slate Path Capital LPUnited States$6.734B44
Susquehanna Portfolio Strategies, LLCUnited States$6.727B959
Briar Hall Management LLCUnited States$6.725B2
PRINCIPAL SECURITIES, INC.United States$6.818B1,411
FLPUTNAM INVESTMENT MANAGEMENT COUnited States$6.714B569